Dr. Szabo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2213 Elba St
Duke University Psychiatry Civitan Building RM 120
Durham, NC 27705Phone+1 919-684-2258
Education & Training
Duke University HospitalResidency, Psychiatry, 2009 - 2013
Medical University of the AmericasClass of 2008
Certifications & Licensure
NC State Medical License 2009 - 2025
FL State Medical License 2013 - 2021- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD Start of enrollment: 2017 Apr 25
- Effect of Bupropion on Seizure Threshold in Depressed Patients Start of enrollment: 2017 Aug 25
Publications & Presentations
PubMed
- Xanomeline-trospium (Cobenfy) for Schizophrenia: A Review of the Literature.Colin M Smith, Morgan Santalucia Augustine, Jessica Dorrough, Steven T Szabo, Särä Shadaram
Clinical Psychopharmacology and Neuroscience. 2025-02-28 - Enrichment using speech latencies improves treatment effect size in a clinical trial of bipolar depression.Joshua S Siegel, Alex S Cohen, Steven T Szabo, Sasagu Tomioka, Mark Opler
Psychiatry Research. 2024-10-01 - Evaluating speech latencies during structured psychiatric interviews as an automated objective measure of psychomotor slowing.Alex S Cohen, Zachary Rodriguez, Mark Opler, Brian Kirkpatrick, Snezana Milanovic
Psychiatry Research. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
